Arena Pharma (ARNA) Misses Q3 EPS by 14c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. USO
7. STZ
8. CRGY
9. AAPL
10. SPY

Go back to Arena Pharma (ARNA) Misses Q3 EPS by 14c

Arena Reports Third Quarter Financial Results with Continued Progress on Clinical Programs

November 7, 2019 4:01 PM EST

SAN DIEGO, Nov. 7, 2019 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the third quarter ended September 30, 2019.

"Arena continues to have a strong 2019 and we remain highly focused on achieving several key clinical and regulatory goals. This year we have initiated multiple important trials, including the... More